Navigation Links
Cancer gene mystery to be cracked!

A major research project is to be launched by researchers from the UK and Netherlands in the hope of identifying the cluster of genes associated with cancer. The research will be led by Dr. Julian Downward from Cancer Research UK’s London Research Institute, along with Dr. René Bernards of the Netherlands Cancer Institute. This research will build on the success of the human genome project and will have scientists looking at nearly 10,000 genes, inactivating one at a time to find out precisely what they do and how they contribute to the development of cancer. They hope// that this effort will ultimately lead to the creation of new drugs that target rogue cancer-causing genes.

Scientists will use a process called RNA interference to switch off certain genes and leave others unaffected. This process was first identified as taking place in the nematode worm. It was discovered that the worm used tiny pieces of double-stranded RNA to switch off rogue genes that would otherwise harm it. Subsequently, researchers found that synthetically produced RNA sequences could be used to target genes in human cells. Using this discovery, scientists will bombard cancer cells with 30,000 pieces of interference RNA in an effort to discover the genetic essence of a malignant cell. The researchers will then screen the treated cells for those that have reverted to type and become normal again. They hope that those genes switched off by RNA interference in these cells may represent a crucial group of genes, which future anti-cancer drugs could target.

Dr. Downward concluded that they were confident that they would precisely find out what needs to be taken away from cancerous cells to make it normal again. Sir Paul Nurse, Chief Executive of Cancer Research, UK, on the other hand, added that the next challenge for scientists was to unravel the mystery of each human gene and find out what each gene was doing. This would help in working out which of them are playing import
'"/>




Page: 1 2

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer gene mystery cracked

(Date:7/23/2008)...N, July 23 /PRNewswire/ -- Philip J. Dwyer, presid... offered testimony before the U.S.,Senate Health, ...ttee on,Children and Families today to call for in...as those implemented at YMCAs across the nation, t...en., Dwyer spoke on behalf of the more than 2,600...
(Date:7/23/2008).... Since the idea of using DNA to create faster, s...1994, scientists have been scrambling to develop s.... Now, new research from a professor at Rensselaer... carry out artificial computations, all we have to...sor of Cognitive Science Mark Changizi has begun t...
(Date:7/23/2008)..., July 23 /PRNewswire/ -- Mercy Health Plans, the ... founded in 1994 by the,Sisters of Mercy Health Sy... Medicare Advantage plans to: Mercy MedicareAdvant.... Louis, Illinois and Southwest Missouri,previous...erPlus Options,St. John,s PremierPlus and St. Joh...
(Date:7/23/2008)...Calif., July 23 /PRNewswire-USNewswire/ -- The Ala...ay meeting July 24-26 at the Oakland,Marriott to a...lth outcomes,in individuals from low-income and co...24 U.S. cities and counties will attend. Place Mat...for Political and Economic,Studies, Health Policy ...
Breaking Medicine News(10 mins):Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 2Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 3Health News:Study suggests human visual system could make powerful computer 2Health News:Study suggests human visual system could make powerful computer 3Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2
... decline in the number of women dying at childbirt...s like Bangladesh, Gautemala and Morocco that have...Mortality Ratio (MMR), the number of maternal deat... 2002 and 2003. According to the Sample Registrati...
...nked to an increased risk of certain types of heal...industrial employees, other factors—such as previo...overall health, safety, and productivity, suggests...and Environmental Medicine, official publication o...
... have used stem cells from the hair follicles of m...rocedure// is much more efficient than the other e...erent therapies. This study was undertaken by a t...ology and Development at Rockefeller University in...
... who suffer from persistent iron overload has been...s Consortium. Patients suffering from a rare gene...cell disease need regular blood transfusions. Gene...l infusion at nights by needle and pump which last...
Other Medicine News:Health News:India Lags Far Behind in Controlling Maternal Deaths 2Health News:Concerns About Working Overtime May Be Misplaced 2
(Date:7/22/2008)...eatment with chemotherapy and pegylated enzyme pro...to chemotherapy alone - - Pegylat...RNewswire-FirstCall/ -- Halozyme Therapeutics,Inc...veloping and,commercializing products targeting th...tation of positive pre-clinical animal efficacy da...
(Date:7/22/2008)...uggests That Ekkyo,s New Approach of LASH (Laser A...Scar Healing Physiology, MARSEILLES, France, July...ave Technology) a photomedicine company, which dev...scar prevention and reduction, announced today,the...Surgery and Medicine*,reporting the results of a p...
(Date:7/21/2008)...Summary of data from five 2008 conferences, GAITH...oration, a,privately held company developing gene ...nt an update on the VRX496 Phase I and Phase II,cl...ocacy community. VRX496,is an investigational gene...on will take place on Thursday, July 24, 2008 at 1...
(Date:7/21/2008)...ly 21 /- Bioimpedance spectroscopy (B...ds of subclinical assessment of,lymphedema in brea... in the,July 20 issue of Journal of Clinical Oncol...d "Lymphedema After Breast Cancer: Incidence, Risk...paper, authored by Sandra Hayes, PhD.,and colleag...
Breaking Medicine Technology:Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 3New Taxotere 28R 29 28docetaxel 29 Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium 28SABCS 29 7856 1New Taxotere 28R 29 28docetaxel 29 Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium 28SABCS 29 7856 2New Taxotere 28R 29 28docetaxel 29 Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium 28SABCS 29 7856 3New Taxotere 28R 29 28docetaxel 29 Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium 28SABCS 29 7856 4New Taxotere 28R 29 28docetaxel 29 Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium 28SABCS 29 7856 5Is infant male circumcision an abuse of the rights of the child 3F 7852 1Is infant male circumcision an abuse of the rights of the child 3F 7852 2Roger Kornberg to present lecture at the Joint Biophysical Society IUPAB Meeting 1499 1Concept of patients charters inadequate 7849 1Concept of patients charters inadequate 7849 2
...007 - Cougar Biotechnology,Inc. (OTCBB: CGRB) tod...se II data on the Company,s prostate cancer drug c...d at the American Society,of Clinical Oncology (AS...e in Chicago, Illinois. The data was presented in ... part of the poster,discussion session for genitou...
...Newswire-FirstCall/ --,Bionovo, Inc.,s lead drug c...or the treatment of hot flashes associated with me...lled in the company,s,double-blind, placebo- contr...men with 50 or more moderate to severe hot flashes...t groups receiving,MF101 (5 grams/day), MF101 (10 ...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 6Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 2Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 3Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 5
The neonate/pediatric blanket provides warmth to neonates, newborns and small children. The blanket may be used under the patient and comes with a drape that is placed on top of the patient to help r
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and
A smaller version of the Model 525 lower body blanket, this blanket is ideal for warming the large child or small adult during upper body surgery.
This pediatric blanket is a smaller version of the full body blanket, providing warmth to smaller patients during recovery.
Medicine Products: